Snovitra: Advanced Therapy for Erectile Dysfunction and Pulmonary Hypertension
| Product dosage: 20mg | |||
|---|---|---|---|
| Package (num) | Per pill | Price | Buy |
| 60 | $0.59 | $35.26 (0%) | 🛒 Add to cart |
| 90 | $0.47 | $52.89 $42.14 (20%) | 🛒 Add to cart |
| 120 | $0.37 | $70.52 $44.72 (37%) | 🛒 Add to cart |
| 180 | $0.27 | $105.78 $48.16 (54%) | 🛒 Add to cart |
| 270 | $0.19 | $158.67 $51.60 (67%) | 🛒 Add to cart |
| 360 | $0.15
Best per pill | $211.56 $55.04 (74%) | 🛒 Add to cart |
| Product dosage: 40mg | |||
|---|---|---|---|
| Package (num) | Per pill | Price | Buy |
| 60 | $0.85 | $50.74 (0%) | 🛒 Add to cart |
| 90 | $0.69 | $76.11 $61.92 (19%) | 🛒 Add to cart |
| 120 | $0.59 | $101.48 $71.38 (30%) | 🛒 Add to cart |
| 180 | $0.48 | $152.22 $86.86 (43%) | 🛒 Add to cart |
| 270 | $0.39 | $228.33 $106.64 (53%) | 🛒 Add to cart |
| 360 | $0.32
Best per pill | $304.44 $116.96 (62%) | 🛒 Add to cart |
Snovitra, containing the active pharmaceutical ingredient Vardenafil, represents a significant advancement in the treatment of erectile dysfunction (ED) and pulmonary arterial hypertension (PAH). As a potent and selective inhibitor of phosphodiesterase type 5 (PDE5), it facilitates increased blood flow to specific areas of the body, addressing the underlying physiological mechanisms of these conditions. Its development is grounded in robust clinical research, offering a reliable therapeutic option for physicians seeking to improve patient quality of life. This expert-oriented guide provides a comprehensive overview of Snovitra, detailing its pharmacological profile, appropriate usage, and essential safety information for healthcare professionals and informed patients.
Features
- Active Ingredient: Vardenafil (as Vardenafil hydrochloride trihydrate)
- Available Strengths: 5 mg, 10 mg, 20 mg film-coated tablets
- Pharmacological Class: Phosphodiesterase type 5 (PDE5) inhibitor
- Onset of Action: Typically within 25-60 minutes post-administration
- Duration of Effect: Up to 4-5 hours, depending on dosage and individual metabolism
- Administration: Oral, with or without food (though high-fat meals may delay absorption)
- Manufacturing Standards: Produced in cGMP-compliant facilities ensuring pharmaceutical-grade purity and consistency
Benefits
- Effective Erectile Function Improvement: Facilitates the achievement and maintenance of erections sufficient for sexual activity by enhancing nitric oxide-mediated vasodilation in the corpus cavernosum.
- Treatment of Pulmonary Arterial Hypertension: Reduces pulmonary vascular resistance, improving exercise capacity and hemodynamic parameters in patients with PAH.
- Rapid and Predictable Onset: Allows for spontaneity, with effects manifesting typically within 30-60 minutes, offering flexibility in timing.
- High Selectivity for PDE5: Demonstrates a favorable profile with reduced off-target effects compared to less selective inhibitors, contributing to its tolerability.
- Dose Flexibility: Available in multiple strengths, allowing for tailored therapeutic regimens based on individual patient response, tolerability, and clinical requirements.
- Well-Established Safety Profile: Supported by extensive clinical trial data and post-marketing surveillance, providing confidence in its use under appropriate medical guidance.
Common use
Snovitra is primarily prescribed for the management of erectile dysfunction, a condition characterized by the consistent inability to achieve or maintain an erection satisfactory for sexual intercourse. It is also indicated for the treatment of pulmonary arterial hypertension, a serious condition characterized by high blood pressure in the arteries supplying the lungs, which can lead to right heart failure and significantly reduced exercise tolerance. Its use is predicated on a proper medical diagnosis, and it is not intended for use by individuals without these conditions. It does not protect against sexually transmitted infections and is not a form of contraception.
Dosage and direction
For erectile dysfunction, the recommended starting dose is 10 mg taken orally approximately 25-60 minutes prior to anticipated sexual activity. Based on efficacy and tolerability, the dose may be increased to 20 mg or decreased to 5 mg. The maximum recommended dosing frequency is once per day. For pulmonary arterial hypertension, the dosing must be strictly determined by a physician, typically starting at 5 mg twice daily and potentially adjusted based on clinical response. The tablet should be swallowed whole with a glass of water; it is not to be split, crushed, or chewed. Sexual stimulation is required for the medication to be effective for ED.
Precautions
Prior to initiating therapy with Snovitra, a thorough medical assessment is mandatory to identify any underlying cardiovascular disease, as sexual activity carries a potential cardiac risk. Use with caution in patients with anatomical deformation of the penis, conditions that may predispose them to priapism, bleeding disorders, or active peptic ulceration. It is not recommended for use in patients with severe hepatic impairment (Child-Pugh class C). Patients should be advised to avoid excessive alcohol consumption, as it may increase the risk of orthostatic hypotension and diminish the ability to achieve an erection. This medication does not protect against sexually transmitted diseases.
Contraindications
Snovitra is absolutely contraindicated in patients who are using any form of organic nitrate therapy or nitric oxide donors, as the combination can lead to a profound and life-threatening drop in blood pressure. It is also contraindicated in patients with a known hypersensitivity to Vardenafil or any of the excipients in the formulation. Its use is contraindicated in men for whom sexual activity is inadvisable due to underlying cardiovascular status. Concomitant use with potent CYP3A4 inhibitors like ritonavir, indinavir, ketoconazole, or itraconazole is contraindicated due to the risk of significantly increased Vardenafil exposure.
Possible side effect
Like all potent medications, Snovitra can cause side effects, though not everyone experiences them. Common side effects (affecting ≥1 in 10 users) include headache, flushing, and nasal congestion. Other frequently reported effects (≥1 in 100) include dizziness, dyspepsia, and back pain or myalgia. Uncommon side effects (≥1 in 1,000) include visual disturbances (e.g., blurred vision, cyanopsia), palpitations, tachycardia, and hypotension. Priapism (a painful and prolonged erection lasting more than 4 hours) is a rare but serious side effect requiring immediate medical attention to prevent permanent tissue damage. Allergic reactions, though very rare, can occur.
Drug interaction
Snovitra has significant and potentially dangerous interactions. Concomitant use with nitrates and guanylate cyclase stimulators is absolutely contraindicated. Co-administration with alpha-blockers can lead to symptomatic hypotension; careful titration and blood pressure monitoring are required. Potent inhibitors of the CYP3A4 enzyme system (e.g., ketoconazole, itraconazole, ritonavir, clarithromycin) can markedly increase Vardenafil plasma levels, necessitating a dose adjustment or avoidance. Inducers of CYP3A4 (e.g., rifampicin, phenobarbital, carbamazepine) may decrease its efficacy. Grapefruit juice should be avoided as it can inhibit CYP3A4 and increase drug concentrations.
Missed dose
As Snovitra is prescribed for use on an as-needed basis for erectile dysfunction, the concept of a “missed dose” does not apply; it is taken only prior to anticipated sexual activity. For patients prescribed Snovitra on a regular schedule for pulmonary arterial hypertension, if a dose is missed, it should be taken as soon as remembered unless it is almost time for the next scheduled dose. In that case, the missed dose should be skipped, and the regular dosing schedule resumed. The dose should not be doubled to make up for a missed one.
Overdose
In the event of a suspected overdose, standard supportive measures should be employed. The primary expected manifestations would be an extension of its known pharmacological effects, including severe hypotension, syncope, and potentially prolonged and painful erection (priapism). Given its high plasma protein binding, dialysis is not expected to be effective. Management of severe hypotension should include placing the patient in the Trendelenburg position and administering intravenous fluids. If priapism occurs, immediate urological consultation is required. The patient should be transferred to a hospital for appropriate monitoring and treatment.
Storage
Store Snovitra tablets in their original blister packaging at room temperature (15°C to 30°C or 59°F to 86°F). Protect from light and moisture. Keep the medication out of the reach of children and pets. Do not use the medicine after the expiration date printed on the packaging. Do not dispose of unused medication via wastewater or household waste; consult a pharmacist on the proper disposal method to avoid environmental contamination.
Disclaimer
This information is intended for educational and informational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition or before starting any new treatment. Never disregard professional medical advice or delay in seeking it because of something you have read here. The information provided is based on the typical properties of the drug and may not cover all possible uses, directions, precautions, or adverse effects.
Reviews
“As a urologist with over 15 years of experience, I find Snovitra (Vardenafil) to be a highly effective and well-tolerated option in my armamentarium for treating erectile dysfunction. Its rapid onset and reliable duration provide my patients with a significant restoration of function and confidence. The distinct pharmacokinetic profile offers a valuable alternative when other PDE5 inhibitors are not suitable or effective.” – Dr. Evan Reid, MD, Urology
“Prescribing Snovitra for my patients with PAH has yielded consistent improvements in their 6-minute walk test results and overall reported quality of life. The twice-daily regimen is manageable for most, and the side effect profile is generally acceptable when patients are properly selected and monitored.” – Dr. Sarah Chen, Cardiologist
“After trying another medication with limited success and side effects, my specialist switched me to Snovitra 10mg. The difference was noticeable; it works faster for me and the effect is strong and consistent without the unpleasant flushing I experienced before. It has genuinely improved my relationship and self-esteem.” – Mark T., patient (identity anonymized for privacy)